India approves Gilead's remdesivir to treat severe COVID-19 cases
India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients.
Full Article
India approves Gilead's remdesivir to treat severe COVID-19 cases
Reuters India
0 shares
1 views
You might like
Related news coverage
Gilead slaps multi-thousand-dollar price tag on coronavirus treatment remdesivir
Proactive Investors
Gilead Sciences Inc (NASDAQ:GILD) has announced it will charge thousands of dollars for its investigational drug remdesivir,..
-
Coronavirus: What’s happening in the labs of pharma companies worldwide
Proactive Investors
-
5 firms await regulator’s nod to make Remdesivir
IndiaTimes
-
Gilead Sciences announces approval of Remdesivir in India for patients with severe Covid-19
Indian Express
-
Gilead Sciences' remdesivir shows improvement in coronavirus patients with moderate pneumonia
Proactive Investors